Spruce Biosciences, Inc. (SPRB) Stock Grade

About Spruce Biosciences, Inc.'s fundamentals

Spruce Biosciences is a biotechnology company with a market capitalization of $130.8 million that reported no revenue in its latest annual period, representing a complete year-over-year decline from prior operations. The company posted a net loss for the year, reflecting negative profitability with a net margin of 0.0%, and does not pay a dividend. With no current revenue generation, traditional valuation metrics like P/E ratio and return on equity are not calculable, indicating the company is in a pre-revenue or development stage of its business.